Mikhail Blagosklonny is an oncologist. He has worked hard in his field to find different solutions to major problems and has been a prominent oncologist in the area that he is in. This has led to him being able to learn more about cancer and the treatments that are available for everyone who wants to try new things. Thanks to Mikhail Blagosklonny, there are new opportunities that people have to be able to try new treatments and get more out of the experiences that they have been a part of. Mikhail Blagosklonny does everything that he can to show people what he is capable of and what oncology can do for those who need that help. View his LinkedIn profile
Not only does Mikhail Blagosklonny work to help his patients and the people who he studied cancer for in the first place, he also does what he can to help his peers. He knows that doctors must work together and that oncologists working together is usually one of the major things that contribute to a cure for a disease. He is hoping that working with other oncologists will eventually lead to the cure for cancer. It has already led to major advances in the treatment of the disease.
Since Mikhail Blagosklonny has been working as an oncologist, he has done what he can to work with his peers. One of the things that he did was set up a peer review publication. This was mainly so that him and his peers could collaborate on different cancer findings and things that were going on with the patients that they had. Mikhail Blagosklonny made sure that Oncotarget was geared toward working together and using each other to help with the research in different situations. It has been a huge help and has even led to some solutions for cancer-related problems.
As Mikhail Blagosklonny learned more about cancer and how it has an effect on different systems of the body, he has been able to add more to the peer review publication. In the past, Oncotarget was only for people who were studying cancer but it has now been expanded to include other fields of medicine. Neurologists, endocrinologists and other doctors can collaborate together thanks to Oncotarget. There is a lot of information about each of the diseases that they might study and the effects that they have on the cancer aspect of health. Visit ResearchGate.Net to learn more about Mikhail’s latest work.
The publication is one that is intended for research. People who are studying medicine or who are working as doctors can learn new techniques and information that can be used for their practice. Doctors can consult the once-weekly publication to learn about information on major findings. Since this often happens quickly and it can be hard to figure out what is going on in each of these situations if they are not a part of the field, having something like Oncotarget can be helpful to doctors who want to find information out about the different fields of medicine that may coincide with the things they are doing.